Thoroughbred Financial Services LLC Takes $402,000 Position in Oscar Health, Inc. (NYSE:OSCR)

Thoroughbred Financial Services LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 25,431 shares of the company’s stock, valued at approximately $402,000.

A number of other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after buying an additional 337,850 shares in the last quarter. Formation8 GP LLC acquired a new stake in Oscar Health in the 4th quarter worth approximately $47,480,000. Price T Rowe Associates Inc. MD boosted its stake in Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Oscar Health by 14.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock worth $28,942,000 after purchasing an additional 392,837 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC boosted its stake in Oscar Health by 21.0% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 2,830,947 shares of the company’s stock worth $25,903,000 after purchasing an additional 491,861 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Insider Activity at Oscar Health

In related news, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now owns 140,648 shares in the company, valued at $2,530,257.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares in the company, valued at $6,697,875.42. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares in the company, valued at approximately $2,530,257.52. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is owned by company insiders.

Analyst Ratings Changes

OSCR has been the subject of a number of recent analyst reports. Wells Fargo & Company lifted their target price on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th. Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Bank of America reiterated a “neutral” rating and issued a $21.00 target price (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Baird R W raised shares of Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Robert W. Baird began coverage on shares of Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price for the company. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.17.

Oscar Health Trading Up 1.4 %

Shares of Oscar Health stock opened at $21.92 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a fifty day moving average price of $17.39 and a 200 day moving average price of $17.38. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.44. The stock has a market cap of $5.30 billion, a PE ratio of -54.80, a price-to-earnings-growth ratio of 41.60 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The firm’s revenue was up 44.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.07) earnings per share. Equities research analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.